Macquarie Group LTD Avid Bioservices, Inc. Transaction History

Macquarie Group LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.4 - $14.04 $18,828 - $28,122	2,003 Added 1.99%	102,694 $969,000
Q2 2023 Aug 14, 2023	BUY	$12.96 - $20.93 $199,324 - $321,903	15,380 Added 18.03%	100,691 $1.41 Million
Q1 2023 May 15, 2023	SELL	$13.48 - $18.79 $13,870 - $19,334	-1,029 Reduced 1.19%	85,311 $1.6 Million
Q4 2022 Feb 21, 2023	SELL	$12.61 - $18.74 $338,540 - $503,112	-26,847 Reduced 23.72%	86,340 $1.19 Million
Q3 2022 Nov 14, 2022	SELL	$15.33 - $20.36 $15,253 - $20,258	-995 Reduced 0.87%	113,187 $2.18 Million
Q2 2022 Aug 15, 2022	BUY	$11.63 - $21.55 $6,419 - $11,895	552 Added 0.49%	114,182 $1.74 Million
Q1 2022 May 16, 2022	BUY	$16.63 - $27.73 $59,485 - $99,190	3,577 Added 3.25%	113,630 $2.32 Million
Q4 2021 Feb 11, 2022	BUY	$20.7 - $34.18 $56,511 - $93,311	2,730 Added 2.54%	110,053 $3.21 Million
Q3 2021 Nov 12, 2021	BUY	$19.05 - $28.32 $921,467 - $1.37 Million	48,371 Added 82.05%	107,323 $2.32 Million
Q2 2021 Aug 13, 2021	BUY	$18.93 - $25.65 $1.12 Million - $1.51 Million	58,952 New	58,952 $1.51 Million

188

68.4M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $776M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.